Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensity-modulated radiotherapy and cisplatin-based chemotherapy for anal cancer: long-term outcomes at a single institution.
Gerardi MA, Zerella MA, Bergamaschi L, Ferrari A, Arculeo S, Bagnardi V, Frassoni S, Petz W, Fodor C, Emiro F, Cattani F, Leonardi MC, Zampino MG, Jereczek-Fossa BA. Gerardi MA, et al. Among authors: arculeo s. Int J Colorectal Dis. 2023 May 10;38(1):123. doi: 10.1007/s00384-023-04400-1. Int J Colorectal Dis. 2023. PMID: 37162567
Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
Dell'Acqua V, Surgo A, Arculeo S, Zerella MA, Bagnardi V, Frassoni S, Zampino MG, Ravenda PS, Rotundo MS, Kraja F, Kobiela J, Spychalski P, Fodor C, Gerardi MA, Cattani F, Bazani A, Petz W, Glynne-Jones R, Orecchia R, Leonardi MC, Jereczek-Fossa BA. Dell'Acqua V, et al. Among authors: arculeo s. Int J Colorectal Dis. 2020 Apr;35(4):685-694. doi: 10.1007/s00384-020-03517-x. Epub 2020 Feb 8. Int J Colorectal Dis. 2020. PMID: 32036405
Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT.
Dell'Acqua V, Kobiela J, Kraja F, Leonardi MC, Surgo A, Zerella MA, Arculeo S, Fodor C, Ricotti R, Zampino MG, Ravenda S, Spinoglio G, Biffi R, Bazani A, Luraschi R, Vigorito S, Spychalski P, Orecchia R, Glynne-Jones R, Jereczek-Fossa BA. Dell'Acqua V, et al. Among authors: arculeo s. Med Oncol. 2018 Mar 28;35(5):59. doi: 10.1007/s12032-018-1118-3. Med Oncol. 2018. PMID: 29594584
Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique.
Zerella MA, Dicuonzo S, Frassoni S, Zaffaroni M, Gerardi MA, Morra A, Rojas DP, Arculeo S, Bergamaschi L, Fodor C, Emiro F, Piccolo C, Bagnardi V, Cattani F, Galimberti V, Veronesi P, Orecchia R, Leonardi MC, Jereczek-Fossa BA. Zerella MA, et al. Among authors: arculeo s. J Cancer Res Clin Oncol. 2022 Apr;148(4):823-835. doi: 10.1007/s00432-021-03907-w. Epub 2022 Jan 6. J Cancer Res Clin Oncol. 2022. PMID: 34989858 Free PMC article.
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA, Maucieri A, Marvaso G, Gandini S, Fodor C, Zerini D, Riva G, Alessandro O, Surgo A, Volpe S, Fanetti G, Arculeo S, Zerella MA, Parisi S, Maisonneuve P, Vavassori A, Cattani F, Cambria R, Garibaldi C, Starzyńska A, Musi G, De Cobelli O, Ferro M, Nolè F, Ciardo D, Orecchia R. Jereczek-Fossa BA, et al. Among authors: arculeo s. Med Oncol. 2018 Nov 27;36(1):9. doi: 10.1007/s12032-018-1233-1. Med Oncol. 2018. PMID: 30483899
Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series.
Francia CM, Marvaso G, Piperno G, Gandini S, Ferrari A, Zerella MA, Arculeo S, Sibio D, Fodor C, Pepa M, Trivellato S, Rondi E, Vigorito S, Cattani F, Spaggiari L, De Marinis F, Orecchia R, Ciardo D, Jereczek-Fossa BA. Francia CM, et al. Among authors: arculeo s. Neoplasma. 2020 May;67(3):684-691. doi: 10.4149/neo_2020_190717N645. Epub 2020 Mar 18. Neoplasma. 2020. PMID: 32182088
The emerging role of radiation therapists in the contouring of organs at risk in radiotherapy: analysis of inter-observer variability with radiation oncologists for the chest and upper abdomen.
Arculeo S, Miglietta E, Nava F, Morra A, Leonardi MC, Comi S, Ciardo D, Fiore MS, Gerardi MA, Pepa M, Gugliandolo SG, Livi L, Orecchia R, Jereczek-Fossa BA, Dicuonzo S. Arculeo S, et al. Ecancermedicalscience. 2020 Jan 6;14:996. doi: 10.3332/ecancer.2020.996. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32153651 Free PMC article.
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment.
Ricotti R, Seregni M, Ciardo D, Vigorito S, Rondi E, Piperno G, Ferrari A, Zerella MA, Arculeo S, Francia CM, Sibio D, Cattani F, De Marinis F, Spaggiari L, Orecchia R, Riboldi M, Baroni G, Jereczek-Fossa BA. Ricotti R, et al. Among authors: arculeo s. Med Phys. 2018 Apr;45(4):1360-1368. doi: 10.1002/mp.12804. Epub 2018 Mar 12. Med Phys. 2018. PMID: 29431863 Free article.
Carotid blowout syndrome after reirradiation for head and neck malignancies: a comprehensive systematic review for a pragmatic multidisciplinary approach.
Alterio D, Turturici I, Volpe S, Ferrari A, Russell-Edu SW, Vischioni B, Mardighian D, Preda L, Gandini S, Marvaso G, Augugliaro M, Durante S, Arculeo S, Patti F, Boccuzzi D, Casbarra A, Starzynska A, Santoni R, Jereczek-Fossa BA. Alterio D, et al. Among authors: arculeo s. Crit Rev Oncol Hematol. 2020 Nov;155:103088. doi: 10.1016/j.critrevonc.2020.103088. Epub 2020 Aug 25. Crit Rev Oncol Hematol. 2020. PMID: 32956946 Review.
Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
Franceschini D, Loi M, Chiola I, Arculeo S, Marzo M, Fernandes B, Masci G, Torrisi R, Tinterri C, Testori A, Santoro A, Scorsetti M. Franceschini D, et al. Among authors: arculeo s. Clin Breast Cancer. 2021 Jun;21(3):231-238. doi: 10.1016/j.clbc.2020.09.004. Epub 2020 Sep 9. Clin Breast Cancer. 2021. PMID: 33121891 Clinical Trial.